The largest database of trusted experimental protocols

Spinlab hyperpolarizer

Manufactured by GE Healthcare

The SpinLab Hyperpolarizer is a laboratory equipment designed to produce hyperpolarized substances for use in magnetic resonance imaging (MRI) and spectroscopy applications. The device utilizes a magnetic field and microwave irradiation to enhance the nuclear spin polarization of certain isotopes, such as 13C or 129Xe, resulting in improved signal-to-noise ratio in MRI scans.

Automatically generated - may contain errors

3 protocols using spinlab hyperpolarizer

1

Dynamic Nuclear Polarization of Fructose

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dynamic nuclear polarization was performed with a 5.0-T SpinLab Hyperpolarizer (GE Healthcare). A 2.0 M solution of 3 dissolved in water containing 15 mM OX063 trityl radical (Oxford Instruments) was polarized in a 5.0-T SpinLab Hyperpolarizer for 3 hours. The hyperpolarized substrate was ejected from the polarizer via dissolution with a large excess of superheated D2O to a final concentration of 25 mM with a resultant pH of 7.2. Polarization quantification was carried immediately after dissolution. One milliliter of the hyperpolarized dissolution was added to an NMR tube and transferred to a 1-T Spinsolve 13C NMR spectrometer (Magritek, NZ). NMR spectra were acquired every 3 s with a 5° excitation over 3 min. Apparent relaxation time (T1) was fitted to a mono-exponential curve and corrected for flip angle. Thermal polarization was determined from the average spectrum of 1024 scans acquired with 90° flip angle every 10 s. Final polarization values after correcting for flip angles and the apparent T1 were calculated to be 5 to 10% for all HP fructose dissolutions. Substrate concentration was measured by 13C NMR at 14.1 T in the presence of 1 mM Gd-DOTA and 15 mM [13C]-acetate standard. The integral of the C2 carbon of fructose was compared to that of the acetate standard to calculate concentrations.
+ Open protocol
+ Expand
2

Hyperpolarized 13C Pyruvate MRI Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dynamic Nuclear Polarization was performed with a 5.0 T SpinLab Hyperpolarizer (GE). The dose used (0.43mL/kg of 250mM pyruvate) was determined in the initial clinical trial (17 ). The sterile fluid paths, containing [1-13C] pyruvic acid (14.2 M), trityl-OXO63 radical (15 mM), sterile water for injection (USP), and a neutralizing base solution, were prepared under cGMP conditions at MSK Radiochemistry and Molecular Imaging Probes Core Facility and then loaded into the polarizer. Polarization times of approximately 2–3 hours were sufficient to attain 20–40% polarization. Prior to injection, the final injectable product conformance to the acceptance criteria, including pyruvate concentration, pH, residual EPA (electro-paramagnetic agent) concentration, temperature, and polarization level, was established using the in-line automated quality control module (Appendix Table 2). The hyperpolarized sample and 20mL saline flush were injected intravenously at a rate of 5 mL/second.
+ Open protocol
+ Expand
3

Pyruvic Acid Hyperpolarization for In Vivo MRI

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dissolution dynamic nuclear polarization (DNP) was performed with a SpinLab Hyperpolarizer (General Electric) operating at 3.35 T. The sample mixture (100 μl) was composed of 14.2 M [1-13C] pyruvic acid and 15 mM trityl radical (General Electric) [24 (link)]. Spin polarizations of approximately 20% were achieved in 2 h. The samples were dissolved with 11 mL of buffer (40 mM TRIS at pH 7.4, 1 mM EDTA) into a pre-cooled vessel. The pH of the dissolute was titrated to physiological range by stoichiometric addition of NaOH. Animal injection was initiated approximately 20–30 s following dissolution, and 200 μL were injected over approximately 10 s. Dynamic 1D EPSI imaging was initiated at the start of the injection. 2D EPSI was initiated 15 s after the end of injection to allow time for lactate conversion.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!